How to Improve the Air Quality of Your Building

Ensuring good air quality for your building can be quite a task. In recent years, indoor air quality, or IAQ, has been a priority for building management. But with the proper tools and knowledge one can discover the best ways to improve IAQ, and save money while still investing in modern and effective implementations.

What are some ways one can improve a building’s air quality without overspending?

In an episode of “10 Minutes to a Better Building,” host Michelle Dawn Mooney interviewed Josh Howell, the Commercial Territory Manager at Dynamic Air Quality Solutions, about the basics of indoor air quality and how companies and institutions can go about revamping their current systems to meet good indoor air standards.

Mooney and Howell also talked about …

  1. The long-term benefits of improving indoor air quality, particularly in schools and healthcare facilities
  2. Some of the present challenges when it comes filtering and upgrading
  3. What cost-effective solutions can mean for larger buildings, such as museums

“Our stuff’s built to last years with no maintenance — you put it in and you don’t touch it. Smithsonian African American museum has our VA product and they went six years without one dollar and one minute spent on changing filters, vice, five, six, seven changeouts a year for some facilities. I mean the savings there and just the burden we’ve taken off the owner, that’s what I see from a feedback loop that you really can’t even put a price on,” said Howell.

Josh Howell is the Commercial Territory Manager at Dynamic Air Quality Solutions. He’s been with the company since 2017 and is a graduate of the U.S. United States Naval Academy.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More